Mark L. Hartman

10.1k citations
103 papers · 7.3k indexed · 5 hit papers · h-index 46

Mark L. Hartman

98 papers receiving 7.0k citations

Hit Papers

Tirzepatide for Metabolic D...3532020202620222024100200300400500

Peers

Mark L. Hartman
Comparison fields: 5 of 136
  • Endocrinology, Diabetes and Metabolism 4.8k
  • Endocrine and Autonomic Systems 1.3k
  • Physiology 2.4k
  • Behavioral Neuroscience 193
  • Cell Biology 551
Replace Fausto Santeusanio with:
Fausto Santeusanio Italy
Andrea Fabbri Italy
Martin Bidlingmaier Germany
Michael C. Riddell Canada
Erik Endert Netherlands
William S. Evans United States
Anton Luger Austria
Pierpaolo De Feo Italy
Peter Y. Liu United States
Randall J. Urban United States
Mark L. Hartman relative to Fausto Santeusanio Italy Fausto Santeusanio's profile →
Citations per field
00.5×10×12.9×
Fausto Santeusanio · 1×
Citations per year

Countries citing papers authored by Mark L. Hartman

Since Specialization
Citations

This map shows the geographic impact of Mark L. Hartman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark L. Hartman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark L. Hartman more than expected).

Fields of papers citing papers by Mark L. Hartman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark L. Hartman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark L. Hartman. The network helps show where Mark L. Hartman may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Mark L. Hartman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mark L. Hartman Line = papers co-authored together Mark L. Hartman links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20251
2 20251
3 20250
4 202418
5
Tirzepatide for Metabolic Dysfunction–Associated Steatohepatitis with Liver Fibrosisbreakdown →
2024353
6 200965
7 200340
8 2002239
9 2002137
10 2001159
11 20002
12 1999186
13 199820
14 199717
15 199745
16 1993117
17 1993154
18 199380
19 199262
20 1990108

About Mark L. Hartman

Mark L. Hartman is a scholar working on Endocrinology, Diabetes and Metabolism, Endocrine and Autonomic Systems and Physiology, having authored 103 papers that have together received 7.3k indexed citations. Recurring topics across this work include Growth Hormone and Insulin-like Growth Factors (48 papers), Pituitary Gland Disorders and Treatments (18 papers), Diet and metabolism studies (17 papers), Liver Disease Diagnosis and Treatment (15 papers), Diabetes Treatment and Management (11 papers), Metabolism, Diabetes, and Cancer (10 papers), Regulation of Appetite and Obesity (10 papers) and Muscle metabolism and nutrition (8 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (4.8k citations), Endocrine and Autonomic Systems (1.3k citations) and Physiology (2.4k citations). Mark L. Hartman has collaborated with scholars based in United States, Netherlands and United Kingdom. Frequent co-authors include Michael O. Thorner, Johannes D. Veldhuis, Arthur Weltman, Judy Y. Weltman, Axel Haupt, Suzan S. Pezzoli, Michael L. Johnson, Jill A. Kanaley, Jody L. Clasey and Yu Du. Their work appears in journals such as The Journal of Clinical Endocrinology & Metabolism, Medicine & Science in Sports & Exercise, Diabetes Obesity and Metabolism, Journal of Applied Physiology and Diabetes.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026